Company
Apontis Pharma AG
Headquarters: Monheim am Rhein, Germany
Employees: 195
CEO: Mr. Karlheinz Gast
Market Cap
€39.8 Million
EUR as of Jan. 1, 2024
US$43.9 Million
Apontis Pharma AG Categories
Germany Healthcare Drug Manufacturers—Specialty & GenericGermany Healthcare Germany Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It supplies products in the field of respiratory diseases, heart failure, and hypertension to the pharmaceutical market. The company is based in Monheim am Rhein, Germany.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Apontis Pharma AG has the following listings and related stock indices.
Stock: FSX: APPH wb_incandescent
Stock: XETR: APPH wb_incandescent